OP Asset Management’s Corcept Therapeutics CORT Stock Holding History

OP Asset Management’s Portfolio CORT Stock Details CORT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,893	Closed	-$318K	–	776
2026 Q1	$318K	Buy	7,893 +3,329	+73%	+$124K	﹤0.01%	701
2025 Q4	$159K	Sell	4,564 -11,227	-71%	-$882K	﹤0.01%	744
2025 Q3	$1.31M	Hold	15,791	–	–	0.02%	548
2025 Q2	$1.16M	Buy	15,791 +390	+3%	+$28.3K	0.02%	587
2025 Q1	$1.76M	Buy	+15,401	New	+$937K	0.03%	470

Other funds holding CORT

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

FWP

FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

KCM

Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

LSERS

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

OP Asset Management's CORT Position: Q2 2026 in Review

OP Asset Management sold out of Corcept Therapeutics (CORT) in Q2 2026, closing a stake of 7,893 shares — an estimated $318K sold.

OP Asset Management first reported a position in CORT in Q1 2025 and held it in 5 quarters. The position peaked at $1.76M in Q1 2025. 113 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

OP Asset Management reported no remaining Corcept Therapeutics position as of Q2 2026 after selling out during the quarter.
OP Asset Management sold 7,893 Corcept Therapeutics shares in Q2 2026, an estimated $318K.
OP Asset Management first reported a position in Corcept Therapeutics in Q1 2025 and held it in 5 quarters.
OP Asset Management's Corcept Therapeutics position peaked at $1.76M in Q1 2025.
113 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on OP Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.